{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:04:32Z","timestamp":1767848672210,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vaccine.2019.01.008","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T17:28:17Z","timestamp":1547918897000},"page":"1016-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Persistence of bactericidal antibodies 4\u202fyears after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D)"],"prefix":"10.1016","volume":"37","author":[{"given":"Corwin A.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hedrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab","family":"Bassily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.01.008_b0005","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.008_b0010","unstructured":"Centers for Disease Control and Prevention. Meningococcal Disease. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington DC: Public Health Foundation; 2015. p. 231-46"},{"key":"10.1016\/j.vaccine.2019.01.008_b0015","series-title":"Meningococcal meningitis - Fact sheet","author":"World Health Organization (WHO)","year":"2018"},{"key":"10.1016\/j.vaccine.2019.01.008_b0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4161\/hv.7.1.13692","article-title":"Cost of acute hospitalization and post-discharge follow-up care for meningococcal disease in the US","volume":"7","author":"Davis","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2019.01.008_b0025","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jadohealth.2016.03.041","article-title":"Deciphering the burden of meningococcal disease: conventional and under-recognized elements","volume":"59","author":"Martinon-Torres","year":"2016","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2019.01.008_b0030","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","article-title":"The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease","volume":"29","author":"Harrison","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2019.01.008_b0035","article-title":"Current epidemiology and trends in meningococcal disease-United States, 1996\u20132015","author":"MacNeil","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.008_b0040","first-page":"1","article-title":"Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep."},{"key":"10.1016\/j.vaccine.2019.01.008_b0045","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2019.01.008_b0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/500512","article-title":"Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine","volume":"193","author":"Vu","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.008_b0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.inf.0000129686.12470.e6","article-title":"Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine","volume":"23","author":"Granoff","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.01.008_b0060","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/j.vaccine.2005.03.031","article-title":"Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children","volume":"23","author":"Granoff","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.008_b0065","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2193","article-title":"Effectiveness and duration of protection of one dose of a meningococcal conjugate vaccine","volume":"139","author":"Cohn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.01.008_b0070","first-page":"72","article-title":"Updated recommendations for use of meningococcal conjugate vaccines \u2013- Advisory Committee on Immunization Practices (ACIP), 2010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.01.008_b0075","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1016\/j.vaccine.2016.09.003","article-title":"Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine","volume":"34","author":"Robertson","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.008_b0080","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/INF.0b013e318268dfe4","article-title":"Safety and immunogenicity of a quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants and toddlers: three multicenter phase III studies","volume":"31","author":"Pina","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.01.008_b0085","unstructured":"Hou VC, Bybel MJ, Hu B, Hildreth S. Validation of serum bactericidal assay using human complement (SBA-HC) (Poster P 066). In: 11th EMGM Congress 2011. Ljubljana, Slovenia. p. 169-70."},{"key":"10.1016\/j.vaccine.2019.01.008_b0090","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2013serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.008_b0095","unstructured":"U. S. Food and Drug Administration. Summary Basis for Regulatory Action, April 14, 2011. Rockville, MD2011."},{"key":"10.1016\/j.vaccine.2019.01.008_b0100","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/INF.0000000000000438","article-title":"Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescents","volume":"33","author":"Baxter","year":"2014","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:30:27Z","timestamp":1759401027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19300398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0264410X19300398"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence of bactericidal antibodies 4\u202fyears after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sanofi Pasteur Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}